Centre for Molecular Pathology

The Centre for Molecular Pathology is a collaborative initiative between The Royal Marsden and The Institute of Cancer Research, aiming to identify the molecular mechanisms that drive cancers and to target them with a new generation of treatments.

Centre for Molecular Pathology

The purpose-built centre in Sutton, which was opened in 2012 by Professor Dame Sally Davies, Chief Medical Officer of England, provides an innovative environment with state-of-the art laboratories, bringing together world experts in molecular pathology, bioinformatics and translational research.

The centre’s research objectives aim to accelerate the embedding of personalised medicine as a routine part of cancer care for patients. The focus will be to develop molecular diagnostics and biomarkers for cancer to allow patient treatment to be personalised. Researchers aim to identify reliable biomarkers of disease prognosis or treatment response, and new molecular targets for a range of tumour types. This will drive the development of new cancer drugs.

The Centre for Molecular Pathology is funded through the NIHR Biomedical Research Centre at The Royal Marsden.